Stay updated on XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s version label changes from v3.6.6 to v3.7.0, signaling a software update to the history view of the study record.SummaryDifference0.1%

- Check44 days agoChange DetectedThe study record history shows the latest revision updated from v3.6.5 to v3.6.6, reflecting a metadata update to the page's version history.SummaryDifference0.1%

- Check59 days agoChange DetectedAn older history entry dated 2026-05-14 was removed and a new Study Status entry dated 2026-08-11 was added, marking an update to the trial's recruitment status in the record.SummaryDifference0.3%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates an updated version of the study record history interface.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry, v3.6.4, has been added to the Study Record Versions. The previous revision, v3.6.3, is no longer listed in the latest version set.SummaryDifference0.1%

Stay in the know with updates to XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.